Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$4.17 - $5.74 $63,154 - $86,932
-15,145 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$5.28 - $9.64 $934 - $1,706
-177 Reduced 1.16%
15,145 $80,000
Q4 2020

Feb 16, 2021

BUY
$5.75 - $7.13 $23,563 - $29,218
4,098 Added 36.51%
15,322 $100,000
Q2 2020

Aug 14, 2020

SELL
$6.43 - $9.86 $103,130 - $158,144
-16,039 Reduced 58.83%
11,224 $81,000
Q1 2020

May 15, 2020

SELL
$6.36 - $10.05 $151,889 - $240,014
-23,882 Reduced 46.69%
27,263 $189,000
Q4 2019

Feb 14, 2020

BUY
$8.49 - $12.81 $14,594 - $22,020
1,719 Added 3.48%
51,145 $451,000
Q3 2019

Nov 14, 2019

SELL
$5.58 - $14.47 $109,981 - $285,203
-19,710 Reduced 28.51%
49,426 $554,000
Q2 2019

Aug 14, 2019

BUY
$5.22 - $9.08 $118,279 - $205,743
22,659 Added 48.75%
69,136 $419,000
Q1 2019

May 15, 2019

BUY
$5.35 - $9.82 $185,864 - $341,156
34,741 Added 296.02%
46,477 $366,000
Q4 2018

Feb 14, 2019

SELL
$3.43 - $6.19 $84,528 - $152,546
-24,644 Reduced 67.74%
11,736 $58,000
Q3 2018

Nov 14, 2018

BUY
$4.75 - $14.5 $52,387 - $159,920
11,029 Added 43.51%
36,380 $173,000
Q2 2018

Aug 14, 2018

SELL
$13.3 - $17.45 $17,303 - $22,702
-1,301 Reduced 4.88%
25,351 $345,000
Q1 2018

May 15, 2018

BUY
$14.7 - $24.95 $46,878 - $79,565
3,189 Added 13.59%
26,652 $428,000
Q4 2017

Feb 14, 2018

SELL
$19.9 - $29.25 $463,550 - $681,349
-23,294 Reduced 49.82%
23,463 $544,000
Q3 2017

Nov 14, 2017

BUY
$15.1 - $19.25 $706,030 - $900,072
46,757
46,757 $863,000

Others Institutions Holding LCI

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About LANNETT CO INC


  • Ticker LCI
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 42,960,000
  • Market Cap $1.29M
  • Description
  • Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...
More about LCI
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.